Imago BioSciences, Inc. Common stock
IMGO
IMGO was delisted on the 10th of January, 2023.
59 hedge funds and large institutions have $576M invested in Imago BioSciences, Inc. Common stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
13% more funds holding
Funds holding: 52 → 59 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $607M → $576M (-$30.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.5M |
| 2 |
BlackRock
New York
|
+$40.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.71M |
| 4 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$6.39M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$70.4M |
| 2 |
Blackstone Inc
New York
|
-$19.5M |
| 3 |
Millennium Management
New York
|
-$3.6M |
| 4 |
HF
HRT Financial
New York
|
-$1.56M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.45M |
IMGO Hedge Fund Activity: Q1 2022 in Review
59 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q1 2022, worth a combined $576M — down 5.1% from $607M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IMGO positions and 6 closed out — a net gain of 7 holders — while 26 added to existing stakes and 14 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $41.5M. The largest seller was Frazier Management, exiting entirely with an estimated $70.4M sold.
- 59 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q1 2022, up from 52 in Q4 2021.
- Funds reported $576M of Imago BioSciences, Inc. Common stock stock for Q1 2022, down 5.1% quarter-over-quarter.
- 13 funds opened new Imago BioSciences, Inc. Common stock positions in Q1 2022 and 6 closed out, a net change of +7 holders.
- The largest Imago BioSciences, Inc. Common stock buyer in Q1 2022 was Fidelity Investments, an estimated $41.5M added.
- The largest Imago BioSciences, Inc. Common stock seller in Q1 2022 was Frazier Management, an estimated $70.4M sold.
Based on aggregated 13F filings for Q1 2022.